AD

Phenyl bromoacetate(CAS: 620-72-4)

Phenyl bromoacetate
CAS Number

Related Products

Other Suppliers for Phenyl bromoacetate

Basic Information

Molecular Formula
C8H7BrO2
Molecular Weight
215.05 g/mol

Physical Properties

Melting Point
31-33 °C (lit.)
Boiling Point
134 °C/15 mmHg(lit.)
Density
1.508 g/mL at 25 °C(lit.)
Water Solubility
Soluble in ethanol and ether, insoluble in water.

Chemical Identifiers

SMILES
C1=CC=C(C=C1)OC(=O)CBr
InChIKey
UEWYUCGVQMZMGY-UHFFFAOYSA-N

Database References

MDL Number
MFCD00192391

FAQ

Phenyl bromoacetate (CAS: 620-72-4) is regulated under the Globally Harmonized System (GHS), which classifies it as a skin and eye irritant. In the European Union, it falls under the REACH regulations, requiring registration and evaluation. The U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) also have specific requirements for handling and disposal. Ensure compliance with local and international chemical safety regulations.
Alternatives to phenyl bromoacetate include other bromoacetates, such as methyl bromoacetate or ethyl bromoacetate. Other synthetic methods like using bromoacetic acid and phenylmagnesium bromide can also be considered. These alternatives offer similar functionality but may vary in reactivity and ease of use.
Phenyl bromoacetate (CAS: 620-72-4) is primarily used in the synthesis of pharmaceuticals and agrochemicals. Research trends indicate an increasing demand for this compound due to its role in developing new drug molecules. Market analysis shows a steady demand with potential growth in emerging markets and biotechnology sectors.
Waste containing phenyl bromoacetate (CAS: 620-72-4) should be collected in appropriate containers and disposed of through a licensed hazardous waste facility. Incineration is a common method, but ensure it meets environmental protection standards. Always follow local regulations and safety guidelines to minimize environmental impact and ensure worker safety.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

enkepharma@126.com